Literature DB >> 20298133

A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays.

Chiara Caselli1, Ombretta Melaiu, Maristella Maltinti, Silvia Del Ry, Manuela Cabiati, Tommaso Prescimone, Danilo Neglia, Daniela Giannessi.   

Abstract

BACKGROUND: Adiponectin, present in different multimeric forms in circulation, is increasingly used in clinical settings as a cardiometabolic marker. The development of several commercially available enzyme-linked immunosorbent assays (ELISA) has allowed for the widespread measurement of adiponectin in research as well as in clinical practice. The comparative performance of these assays is thus an issue of major relevance.
METHODS: The analytical performance of four different ELISAs (LINCO, B-Bridge, SPIbio and ALPCO) was evaluated. Samples from 102 cardiac patients and 40 healthy subjects were tested using LINCO and ALPCO. The latter is able to measure the concentrations of multimers. For the multimer assay, an error propagation study was performed. A subset of subjects was tested by all four ELISAs for comparison purposes.
RESULTS: Bland-Altman plots revealed differences between the results of the four ELISAs, mainly for ALPCO. However, a strong correlation between the different ELISAs (ALPCO, r=0.83; B-Bridge, r=0.98; SPIbio, r=0.91 vs. LINCO) was observed. Total adiponectin measured by LINCO showed a better association with cardiac disease [receiver-operating characteristic (ROC) curves] than total and high molecular weight adiponectin measured by ALPCO.
CONCLUSIONS: The results of this study contribute to a better understanding of the methodological features of the several ELISAs, and help in the evaluation and comparison of the relative results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20298133     DOI: 10.1515/CCLM.2010.104

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  4 in total

Review 1.  Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk.

Authors:  Gema Frühbeck; Victoria Catalán; Amaia Rodríguez; Javier Gómez-Ambrosi
Journal:  Adipocyte       Date:  2017-12-05       Impact factor: 4.534

2.  Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure.

Authors:  Daniela Giannessi; Chiara Caselli; Silvia Del Ry; Maristella Maltinti; Silvia Pardini; Stefano Turchi; Manuela Cabiati; Tiziana Sampietro; Nader Abraham; Antonio L'abbate; Danilo Neglia
Journal:  Metabolism       Date:  2010-03-04       Impact factor: 8.694

3.  Discriminatory Value of Adiponectin to Leptin Ratio for COVID-19 Pneumonia.

Authors:  Federica Tonon; Stefano Di Bella; Fabiola Giudici; Verena Zerbato; Ludovica Segat; Raffaella Koncan; Andrea Misin; Barbara Toffoli; Pierlanfranco D'Agaro; Roberto Luzzati; Bruno Fabris; Stella Bernardi
Journal:  Int J Endocrinol       Date:  2022-04-26       Impact factor: 2.803

4.  Ratiometric Measurements of Adiponectin by Mass Spectrometry in Bottlenose Dolphins (Tursiops truncatus) with Iron Overload Reveal an Association with Insulin Resistance and Glucagon.

Authors:  Benjamin A Neely; Kevin P Carlin; John M Arthur; Wayne E McFee; Michael G Janech
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-20       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.